Literature DB >> 6329602

Cannabinoids in glaucoma II: the effect of different cannabinoids on intraocular pressure of the rabbit.

M A ElSohly, E C Harland, D A Benigni, C W Waller.   

Abstract

Thirty-two different cannabinoids were tested for their ability to reduce intraocular pressure (IOP) in the rabbit. These included many of delta 9- and delta 8-THC derivatives and metabolites along with other natural and synthetic cannabinoids. In addition, some non-cannabinoid constituents of Cannabis were screened using the same model. All compounds were administered intravenously, while only a few were tested topically in mineral oil. Water soluble derivatives of delta 9- and delta 8-THC were prepared and tested topically in aqueous solution. The data revealed that certain derivatives of delta 9-and delta 8-THC were more active in lowering IOP than the parent cannabinoids. In addition, compounds other than delta 9- and delta 8-THC and their derivatives were shown to have activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6329602     DOI: 10.3109/02713688409000797

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  9 in total

1.  Enhanced solubility, stability, and transcorneal permeability of δ-8-tetrahydrocannabinol in the presence of cyclodextrins.

Authors:  Ketan Hippalgaonkar; Waseem Gul; Mahmoud A ElSohly; Michael A Repka; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2011-06-03       Impact factor: 3.246

Review 2.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

3.  Ocular Disposition of ∆8-Tetrahydrocannabinol from Various Topical Ophthalmic Formulations.

Authors:  Nagendra S Punyamurthula; Goutham R Adelli; Waseem Gul; Michael A Repka; Mahmoud A ElSohly; Soumyajit Majumdar
Journal:  AAPS PharmSciTech       Date:  2016-11-30       Impact factor: 3.246

4.  Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure.

Authors:  Sally Miller; Laura Daily; Emma Leishman; Heather Bradshaw; Alex Straiker
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

Review 5.  Minor Phytocannabinoids: A Misleading Name but a Promising Opportunity for Biomedical Research.

Authors:  Diego Caprioglio; Hawraz Ibrahim M Amin; Orazio Taglialatela-Scafati; Eduardo Muñoz; Giovanni Appendino
Journal:  Biomolecules       Date:  2022-08-06

Review 6.  Cannabinoids in health and disease.

Authors:  Natalya M Kogan; Raphael Mechoulam
Journal:  Dialogues Clin Neurosci       Date:  2007       Impact factor: 5.986

Review 7.  Marijuana for Glaucoma: A Recipe for Disaster or Treatment?

Authors:  Xiaoshen Sun; Chaoying S Xu; Nisha Chadha; Allshine Chen; Ji Liu
Journal:  Yale J Biol Med       Date:  2015-09-03

Review 8.  Human Metabolites of Cannabidiol: A Review on Their Formation, Biological Activity, and Relevance in Therapy.

Authors:  István Ujváry; Lumír Hanuš
Journal:  Cannabis Cannabinoid Res       Date:  2016-03-01

9.  Cannabidiol Signaling in the Eye and Its Potential as an Ocular Therapeutic Agent.

Authors:  Alyssa Aebersold; Max Duff; Lucy Sloan; Zhao-Hui Song
Journal:  Cell Physiol Biochem       Date:  2021-05-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.